1. Home
  2. GDTC vs NNVC Comparison

GDTC vs NNVC Comparison

Compare GDTC & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • NNVC
  • Stock Information
  • Founded
  • GDTC 2018
  • NNVC 2005
  • Country
  • GDTC Singapore
  • NNVC United States
  • Employees
  • GDTC N/A
  • NNVC N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • NNVC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDTC Health Care
  • NNVC Health Care
  • Exchange
  • GDTC Nasdaq
  • NNVC Nasdaq
  • Market Cap
  • GDTC 28.0M
  • NNVC 24.4M
  • IPO Year
  • GDTC 2023
  • NNVC N/A
  • Fundamental
  • Price
  • GDTC $2.30
  • NNVC $1.23
  • Analyst Decision
  • GDTC Buy
  • NNVC
  • Analyst Count
  • GDTC 1
  • NNVC 0
  • Target Price
  • GDTC $5.00
  • NNVC N/A
  • AVG Volume (30 Days)
  • GDTC 7.3K
  • NNVC 213.1K
  • Earning Date
  • GDTC 01-01-0001
  • NNVC 05-15-2025
  • Dividend Yield
  • GDTC N/A
  • NNVC N/A
  • EPS Growth
  • GDTC N/A
  • NNVC N/A
  • EPS
  • GDTC N/A
  • NNVC N/A
  • Revenue
  • GDTC $368,838.00
  • NNVC N/A
  • Revenue This Year
  • GDTC $5.37
  • NNVC N/A
  • Revenue Next Year
  • GDTC N/A
  • NNVC N/A
  • P/E Ratio
  • GDTC N/A
  • NNVC N/A
  • Revenue Growth
  • GDTC N/A
  • NNVC N/A
  • 52 Week Low
  • GDTC $1.20
  • NNVC $0.94
  • 52 Week High
  • GDTC $4.05
  • NNVC $2.55
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 54.58
  • NNVC 36.88
  • Support Level
  • GDTC $2.25
  • NNVC $1.36
  • Resistance Level
  • GDTC $2.35
  • NNVC $1.46
  • Average True Range (ATR)
  • GDTC 0.08
  • NNVC 0.09
  • MACD
  • GDTC 0.03
  • NNVC -0.03
  • Stochastic Oscillator
  • GDTC 85.29
  • NNVC 19.05

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: